Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,333 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy.
White L, Daly SA, McKenna CJ, Zhestkova N, Leal C, Breatnach F, Smelhaus V, Hung IJ, Kowalczyk J, Ninane J, Mitchell T, Haigh C. White L, et al. Pediatr Hematol Oncol. 2000 Sep;17(6):445-55. doi: 10.1080/08880010050120791. Pediatr Hematol Oncol. 2000. PMID: 10989464 Clinical Trial.
Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: a report from the Australia and New Zealand Children's Cancer Study Group.
McCowage GB, White L, Carpenter P, Lockwood L, Toogood I, Tiedemann K, Shaw PJ. McCowage GB, et al. Among authors: white l. Med Pediatr Oncol. 1997 Aug;29(2):108-14. doi: 10.1002/(sici)1096-911x(199708)29:2<108::aid-mpo8>3.0.co;2-i. Med Pediatr Oncol. 1997. PMID: 9180912 Clinical Trial.
Postoperative chemotherapy in children less than 4 years of age with malignant brain tumors: promising initial response to a VETOPEC-based regimen. A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG).
White L, Kellie S, Gray E, Toogood I, Waters K, Lockwood L, Macfarlane S, Johnston H. White L, et al. J Pediatr Hematol Oncol. 1998 Mar-Apr;20(2):125-30. doi: 10.1097/00043426-199803000-00007. J Pediatr Hematol Oncol. 1998. PMID: 9544162 Clinical Trial.
Actinomycin D-induced hepatotoxicity.
White L, Tobias V, Hughes DW. White L, et al. Pediatr Hematol Oncol. 1989;6(1):53-7. doi: 10.3109/08880018909014582. Pediatr Hematol Oncol. 1989. PMID: 2561915 No abstract available.
3,333 results